Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals

International Journal of Gynecology and Obstetrics

Volumn 115, Issue 3, 2011, Pages 231-234

  Barua, Alka ^a   Mundle, Shuchita ^b   Bracken, Hillary ^c   Easterling, Thomas ^d   Winikoff, Beverly ^c  

^a Government Medical College ^*

^b GOVERNMENT MEDICAL COLLEGE   (India)

^c GYNUITY HEALTH PROJECTS   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Eclampsia; Magnesium sulfate; Pre eclampsia

Indexed keywords

MAGNESIUM SULFATE;

ARTICLE; CLINICAL DECISION MAKING; DRUG BIOAVAILABILITY; DRUG EFFICACY; ECLAMPSIA AND PREECLAMPSIA; FEMALE; GYNECOLOGY; HEALTH CARE FACILITY; HEALTH PRACTITIONER; HUMAN; INDIA; MEDICAL PERSONNEL; NURSING STAFF; POLITICS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PURPOSIVE SAMPLE; SOCIAL ASPECT; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

EID: 80955142733     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2011.07.016     Document Type: Article

References (14)

1. L. Duley Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean Br J Obstet Gynaecol 99 7 1992 547 553
2. Registrar General, India Maternal Mortality in India, 1997-2003: Trends, Causes and Risk Factors 2006 Sample Registration System New Delhi
3. D. Altman, G. Carroli, L. Duley, B. Farrell, J. Moodley, and J. Neilson Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial Lancet 359 9321 2002 1877 1890 (Pubitemid 34615765)
4. M. Aaserud, S. Lewin, S. Innvaer, E.J. Paulsen, A.T. Dahlgren, and M. Trommald Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia BMC Health Serv Res 5 2005 68
5. Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India National List of Essential Medicines 2003 www.who.int http://www.searo.who.int/LinkFiles/Essential-Drugs-and-Medicines- India.pdf Published 2003
6. Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India Indian Public Health Standards (IPHS) for Sub-Centres www.nic.in http://mohfw.nic.in/NRHM/Documents/IPHS-for-SUBCENTRES. pdf Published 2006
7. Projects Gynuity Health Treatment Approaches for Preeclampsia in Low-Resource Settings www.clinicaltrials.gov http://clinicaltrials.gov/ct2/show/ NCT00666133 Published 2008
8. L. Duley, H.E. Matar, M.Q. Almerie, and D.R. Hall Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia Cochrane Database Syst Rev 8 2010 CD007388
9. K. Charmaz Constructing Grounded Theory: A Practical Guide through Qualitative Analysis 2006 Sage Thousand Oaks, California
10. P. Lumbiganon, A.M. Gülmezoglu, G. Piaggio, A. Langer, and J. Grimshaw Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be Bull World Health Organ 85 10 2007 763 767 (Pubitemid 350082916)
11. A.L. Ridge, L.A. Bero, and S.R. Hill Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia BMC Health Serv Res 10 2010 340
12. J.M. Schutte, N.W. Schuitemaker, J. van Roosmalen, E.A. Steegers Dutch Maternal Mortality Committee Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands BJOG 115 6 2008 732 736 (Pubitemid 351514589)
13. R. Fox, and T. Draycott Prefer diazepam for initial control of pre-eclamptic fits BMJ 311 7017 1995 1433
14. J.M. Roberts, J. Villar, and S. Arulkumaran Preventing and treating eclamptic seizures BMJ 325 7365 2002 609 610